Shoulson I - Search Results

1

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.

Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al. Jankovic J, et al. Among authors: shoulson i. Neurology. 1990 Oct;40(10):1529-34. doi: 10.1212/wnl.40.10.1529. Neurology. 1990. PMID: 2215943

2

Duodenal and gastric delivery of levodopa in parkinsonism.

Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I. Kurlan R, et al. Among authors: shoulson i. Ann Neurol. 1988 Jun;23(6):589-95. doi: 10.1002/ana.410230611. Ann Neurol. 1988. PMID: 3408240

3

Early-stage Parkinson's disease: to treat or not to treat.

Jankovic J, Shoulson I, Weiner WJ. Jankovic J, et al. Among authors: shoulson i. Neurology. 1994 Mar;44(3 Suppl 1):S4-7. Neurology. 1994. PMID: 8121578 No abstract available.

4

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease.

Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J, et al. Olanow CW, et al. Among authors: shoulson i. Mov Disord. 1994 Jan;9(1):40-7. doi: 10.1002/mds.870090107. Mov Disord. 1994. PMID: 8139604 Clinical Trial.

5

Safety of rasagiline in elderly patients with Parkinson disease.

Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I; Parkinson Study Group TEMPO and PRESTO Investigators. Goetz CG, et al. Among authors: shoulson i. Neurology. 2006 May 9;66(9):1427-9. doi: 10.1212/01.wnl.0000210692.95595.1c. Neurology. 2006. PMID: 16682679

6

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I; Huntington Study Group. Marder K, et al. Among authors: shoulson i. Neurology. 2009 Aug 4;73(5):385-92. doi: 10.1212/WNL.0b013e3181b04aa2. Neurology. 2009. PMID: 19652143 Free PMC article.

7

Selegiline and Parkinson's disease. Protective and symptomatic considerations.

Golbe LI, Langston JW, Shoulson I. Golbe LI, et al. Among authors: shoulson i. Drugs. 1990 May;39(5):646-51. doi: 10.2165/00003495-199039050-00002. Drugs. 1990. PMID: 2112994 Review. No abstract available.

8

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.

Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators. Schobel SA, et al. Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15. Neurology. 2017. PMID: 29142089 Free PMC article.

9

Coexistent Meige's syndrome and myasthenia gravis. A relationship between blinking and extraocular muscle fatigue?

Kurlan R, Jankovic J, Rubin A, Patten B, Griggs R, Shoulson I. Kurlan R, et al. Among authors: shoulson i. Arch Neurol. 1987 Oct;44(10):1057-60. doi: 10.1001/archneur.1987.00520220055017. Arch Neurol. 1987. PMID: 3632379

10

Clinical research in neurology. From observation to experimentation.

Marshall FJ, Kieburtz K, McDermott M, Kurlan R, Shoulson I. Marshall FJ, et al. Among authors: shoulson i. Neurol Clin. 1996 May;14(2):451-66. doi: 10.1016/s0733-8619(05)70267-x. Neurol Clin. 1996. PMID: 8827182 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page